[Case report: primary hyperfractionated accelerated radiotherapy in a case of hepatocellular carcinoma (HCC)]

Zentralbl Chir. 2007 Aug;132(4):316-21. doi: 10.1055/s-2007-981206.
[Article in German]

Abstract

Background: Hepatocellular carcinomas are among the most frequent solid tumour entities worldwide. Because of the advanced tumour stage frequently observed at diagnosis a tumour resection as a curative treatment option is often impossible. Therefore the consideration of alternative treatment methods (possibly enhancing the chance of a subsequent tumour resection) and the improvement of existing palliative treatment options are gaining considerable importance.

Case report: A 77-years-old female patient was diagnosed to have a rapidly progredient expansion in the liver in August 2003. Due to its large extension a local tumour resection was impossible and therefore a hyperfractionated accelerated radiotherapy up to a total dose of 55.0 Gy (single dose 1.2 Gy / 1.3 Gy 2 daily fractions, 12 fractions per week, overall treatment time: 27 days) was applied to both well-definable expansions (segments IV and V) from September to October 2003.

Results: Despite the large target volume (about 50% of the total liver volume) at an extended HCC and considering the fact that initially symptomatic treatment was aimed at, a curative tumour resectability with subsequent R0 partial liver resection at an interval of 9 months could be achieved by means of radiotherapy treatment.

Publication types

  • Case Reports

MeSH terms

  • Carcinoma, Hepatocellular / diagnostic imaging
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / radiotherapy*
  • Carcinoma, Hepatocellular / surgery*
  • Dose Fractionation, Radiation*
  • Female
  • Follow-Up Studies
  • Humans
  • Liver / pathology
  • Liver Neoplasms / diagnostic imaging
  • Liver Neoplasms / pathology
  • Liver Neoplasms / radiotherapy*
  • Liver Neoplasms / surgery*
  • Magnetic Resonance Imaging
  • Neoadjuvant Therapy*
  • Neoplasm Staging
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome